Distribution of CPRR Immunoassays for BioRad BioPlex Lab Tests.

The Seattle VA Medical Center, operating under the Department of Veterans Affairs Veterans Health Administration (Veterans Integrated Service Network 20), is seeking a single contractor to distribute BioRad BioPlex automated immunoassay instrumentation and reagents for comprehensive laboratory testing. The contractor must provide FDA-approved analyzers capable of performing over 70 distinct immunological tests, including ANA Screens, HIV Antibody Panels, Syphilis testing, viral antibody panels (HSV, CMV, EBV, measles/mumps/rubella/varicella), and specialized panels for vasculitis, celiac disease, antiphospholipid syndrome, and anti-CCP conditions, with specific methodology for differentiating HIV 1 and HIV 2. Key technical requirements include processing capacity of 2,200 samples per hour, support for on-demand testing, and bi-directional Laboratory Information System (LIS) connectivity. The contract will be evaluated based on the contractor's ability to meet the Statement of Work requirements and provide firm-fixed-price service orders based on estimated yearly test volumes detailed in the supporting attachments. The deadline for proposal submission is December 19, 2025, at 5:00 PM Pacific Time.

This solicitation is a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract set aside 100% for small businesses within the NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing), with a size standard of 1,250 employees. No incumbent contractor information is identified in the available documentation. The contract will span five ordering periods from February 1, 2026, through January 31, 2031, with estimated annual test volumes ranging from 12 to 1,524 tests per product line across the 64-product specification list provided. While specific budget values are not disclosed, the government anticipates awarding a firm-fixed-price contract based on the comprehensive five-year pricing breakdown for all required reagents, controls, and consumables detailed in Attachment A. The place of performance is located in Seattle, Washington (98108), at the Seattle VA Medical Center's Pathology Laboratory Medicine department, with the potential for contract expansion as new diagnostic technologies become available on the market.